
The US Supreme Court will examine whether companies should be able to patent human genes they have isolated and identified. This is a decision that could have far-reaching implications for genetic research. An appeals court in August authorized a biotechnology company, Myriad Genetics Inc, to patent two genes it found had links to breast and ovarian cancer -- women with the gene were at a much higher risk of developing the cancers. These ...

via Medindia Health News
More READ

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2012/12/ruling-awaited-on-whether-companies-can.html
No comments:
Post a Comment